What is Zepbound?
Zepbound contains tirzepatide and is a prescription product used in weight management for eligible adults. Lilly’s June 16, 2026 Canadian announcement also describes approval for moderate-to-severe obstructive sleep apnea in adults with obesity, alongside diet and physical activity.
How does Zepbound differ from Mounjaro?
The sleep-apnea indication applies to a defined adult population. It does not establish suitability for every person with sleep apnea or make Zepbound and Mounjaro interchangeable prescriptions.
Zepbound and sleep apnea: the Canadian update
Read the June 2026 Canadian sleep-apnea announcement and ask a clinician how the current product information applies to your situation.
Read the update →Before you fill your prescription
Zepbound and Mounjaro contain tirzepatide. Check the product-specific monograph, prescription and package rather than assuming the two brands have the same terms or coverage.
Ask your pharmacy for a quote showing the exact DIN, package, days supplied, dispensing fee and delivery. If you use an online provider, check visit and membership charges separately.
For insurance, confirm the exact DIN, any prior authorization and your remaining deductible or limits with your plan.
Check coverage steps →Product sources and review details
Sources reviewed 2026-09-20. Check the current Canadian product information with your pharmacist for dosing and safety questions.
Zepbound product source
Clarity in every comparison.